Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

RX 0201

Next Previous
Drug Profile

RX 0201

Alternative Names: Archexin; Archexin-Nano; F-LCAN-RX-0201; RX 0201-N; RX-0201; RX-0201 nanoliposomal; RX-0201-Nano; WGI-0201

Latest Information Update: 28 Apr 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Rexahn Pharmaceuticals
  • Developer Rexahn Pharmaceuticals; The WhiteOak Group
  • Class Antineoplastics; Antisense oligonucleotides
  • Mechanism of Action Proto-oncogene protein c-akt inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Glioblastoma; Pancreatic cancer; Gastric cancer; Renal cell carcinoma; Ovarian cancer
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Pancreatic cancer; Renal cell carcinoma
  • No development reported Liver cancer

Most Recent Events

  • 28 Apr 2025 No recent reports of development identified for phase-I development in Liver-cancer in USA (IV)
  • 22 Oct 2024 Ocuphire Pharma has merged with Opus Genetics to form Opus Genetics
  • 14 Apr 2023 Pharmacodynamics and adverse events data from preclinical studies in Solid tumours were presented at 114th Annual Meeting of the American Association for Cancer Research (AACR-2023)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top